Woodinville-based biotech Nortis has raised $6M in equity funding and is seeking to raise an additional $3.5M
Nortis focuses on “organ-on-chip” technology and hopes to create the 21st century gold standard for the preclinical testing of drugs and vaccines to accelerate the discovery and introduction of new therapies.
The company currently has open roles in human resources, biomanufacturing, and more.